[go: up one dir, main page]

WO2006129092A3 - Use of bacteriophage in medicaments - Google Patents

Use of bacteriophage in medicaments Download PDF

Info

Publication number
WO2006129092A3
WO2006129092A3 PCT/GB2006/001992 GB2006001992W WO2006129092A3 WO 2006129092 A3 WO2006129092 A3 WO 2006129092A3 GB 2006001992 W GB2006001992 W GB 2006001992W WO 2006129092 A3 WO2006129092 A3 WO 2006129092A3
Authority
WO
WIPO (PCT)
Prior art keywords
medicaments
treatment
bacteriophages
prevention
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2006/001992
Other languages
French (fr)
Other versions
WO2006129092A2 (en
Inventor
Laura Jane Violet Piddock
Martin John Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Birmingham
Original Assignee
University of Birmingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Birmingham filed Critical University of Birmingham
Publication of WO2006129092A2 publication Critical patent/WO2006129092A2/en
Publication of WO2006129092A3 publication Critical patent/WO2006129092A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to medicaments suitable for use in the prevention and/or treatment of bacterial infection and/or colonisation. More particularly, the invention relates to medicaments comprising bacteriophages capable of binding to bacterial efflux pump components suitable for use in the prevention or treatment of diseases associated with Gram-negative bacteria. The invention also provides methods of treatment and methods of food preparation utilising such bacteriophages, as well as an assay by which such bacteriophages may be identified.
PCT/GB2006/001992 2005-06-02 2006-06-02 Use of bacteriophage in medicaments Ceased WO2006129092A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511204.0A GB0511204D0 (en) 2005-06-02 2005-06-02 Medicaments
GB0511204.0 2005-06-02

Publications (2)

Publication Number Publication Date
WO2006129092A2 WO2006129092A2 (en) 2006-12-07
WO2006129092A3 true WO2006129092A3 (en) 2007-01-18

Family

ID=34834990

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/001992 Ceased WO2006129092A2 (en) 2005-06-02 2006-06-02 Use of bacteriophage in medicaments

Country Status (2)

Country Link
GB (1) GB0511204D0 (en)
WO (1) WO2006129092A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070292397A1 (en) * 2006-06-19 2007-12-20 Mcnulty Amy K Method for the detection and neutralization of bacteria
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2246420B1 (en) * 2008-02-21 2014-12-31 Ajinomoto Co., Inc. L-cysteine-producing bacterium, and method for production of l-cysteine
US20190142881A1 (en) * 2016-04-25 2019-05-16 Yale University Bacteriophage compositions and uses thereof
CN106868179A (en) * 2017-03-30 2017-06-20 佟青 Efflux pump SMeDEF combines the method for mediation germ oligotrophy unit cell Multiresistant genes positioning with I class integrase gene
CN111088269B (en) * 2019-12-17 2020-11-20 中国科学院深圳先进技术研究院 OprJ-N-M fusion gene and fusion protein thereof, preparation method and use of fusion protein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023848A1 (en) * 1994-03-01 1995-09-08 Merck Patent Gmbh Selective virus culture
WO2002038104A2 (en) * 2000-11-13 2002-05-16 Iowa State University Research Foundation, Inc. Compositions and methods for reducing the amount of salmonella in livestock
WO2003103578A2 (en) * 2002-06-05 2003-12-18 Iowa State University Research Foundation, Inc. Bacteriophage and enzymes lytic to salmonellae
WO2005023010A2 (en) * 2003-09-05 2005-03-17 The University Of Nottingham Disinfection of foodstuffs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023848A1 (en) * 1994-03-01 1995-09-08 Merck Patent Gmbh Selective virus culture
WO2002038104A2 (en) * 2000-11-13 2002-05-16 Iowa State University Research Foundation, Inc. Compositions and methods for reducing the amount of salmonella in livestock
WO2003103578A2 (en) * 2002-06-05 2003-12-18 Iowa State University Research Foundation, Inc. Bacteriophage and enzymes lytic to salmonellae
WO2005023010A2 (en) * 2003-09-05 2005-03-17 The University Of Nottingham Disinfection of foodstuffs

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ANDERSON E S ET AL: "Bacteriophage typing of enteric pathogens and staphylococci and its use in epidemiology.", JOURNAL OF CLINICAL PATHOLOGY. MAY 1956, vol. 9, no. 2, May 1956 (1956-05-01), pages 94 - 127, XP002404413, ISSN: 0021-9746 *
CARLTON R M: "PHAGE THERAPY: PAST HISTORY AND FUTURE PROSPECTS", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, POLISH ACADEMY OF SCIENCES, WROCLAW, PL, vol. 47, no. 5, 1999, pages 267 - 274, XP001199870, ISSN: 0004-069X *
CONNERTON P L ET AL: "Longitudinal study of Campylobacter jejuni bacteriophages and their hosts from broiler chickens", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 70, no. 7, July 2004 (2004-07-01), pages 3877 - 3883, XP002313914, ISSN: 0099-2240 *
EL-SHIBINY A ET AL: "Enumeration and diversity of campylobacters and bacteriophages isolated during the rearing cycles of free-range and organic chickens.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY. MAR 2005, vol. 71, no. 3, March 2005 (2005-03-01), pages 1259 - 1266, XP002404410, ISSN: 0099-2240 *
GERMAN G J ET AL: "The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 308, no. 4, 11 May 2001 (2001-05-11), pages 579 - 585, XP004480454, ISSN: 0022-2836 *
HUSAIN FASAHATH ET AL: "Interaction between the TolC and AcrA proteins of a multidrug efflux system of Escherichia coli.", JOURNAL OF BACTERIOLOGY. DEC 2004, vol. 186, no. 24, December 2004 (2004-12-01), pages 8533 - 8536, XP002404027, ISSN: 0021-9193 *
SCHMIEGER H: "Molecular survey of the Salmonella phage typing system of Anderson.", JOURNAL OF BACTERIOLOGY. MAR 1999, vol. 181, no. 5, March 1999 (1999-03-01), pages 1630 - 1635, XP002404411, ISSN: 0021-9193 *
THIEL KARL: "Old dogma, new tricks--21st Century phage therapy.", NATURE BIOTECHNOLOGY. JAN 2004, vol. 22, no. 1, January 2004 (2004-01-01), pages 31 - 36, XP002404412, ISSN: 1087-0156 *

Also Published As

Publication number Publication date
GB0511204D0 (en) 2005-07-06
WO2006129092A2 (en) 2006-12-07

Similar Documents

Publication Publication Date Title
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
WO2011110655A3 (en) Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease
WO2007130655A3 (en) Phage derived antimicrobial activities
IL213489A0 (en) Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
WO2007085852A3 (en) Antimicrobial materials
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
WO2007090569A8 (en) Conditioned blood composition and method for its production
EP2730576A3 (en) Anti-infective compounds
WO2005103084A3 (en) Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
AU2011206532A8 (en) Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2009108406A3 (en) Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
WO2007117680A3 (en) Methods and compositions for treating bacterial infection
WO2005072826A3 (en) Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
WO2005089738A3 (en) Use and administration of bacterial efflux pump inhibitors
WO2009088549A3 (en) Methods of inhibiting bacterial virulence and compounds relating thereto
WO2008017826A3 (en) Immunogenic proteins of burkholderia pseudomallei and uses thereof
WO2008082692A3 (en) Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
EP2772260A3 (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
WO2011047320A3 (en) Antimicrobial compounds and methods of making and using the same
WO2007126363A3 (en) Antisecretory protein for use in the treatment of compartment syndrome
HK1209031A1 (en) Polysaccharide compositions and methods of use
EP2357191A3 (en) Cyclic antimicrobial peptides
WO2010052575A3 (en) Ngna compositions and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06744053

Country of ref document: EP

Kind code of ref document: A2